ArticleTranslational cancer research2025
Unveiling critical genes and molecular subtypes in ovarian cancer: insights into tumor immunity and carbohydrate-lipid metabolism.
Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ovarian cancer (OC) has the highest mortality rate among all gynecological cancers, yet its pathogenesis remains unclear. This study aims to use integrated bioinformatics methods to identify important biomarkers and subtypes closely related to tumor immunity and fatty acid synthesis in OC. Methods: RNA sequencing data offered with the Gene Expression Omnibus (GEO) were processed. Differentially expressed genes (DEGs) were screened and annotated via Gene Ontology (GO) Enrichment Analysis, Gene Set Variation Analysis (GSVA), and Gene Set Enrichment Analysis (GSEA). Besides, the critical DEGs were used in building the protein-protein interaction (PPI) networks, screening significant subtypes, and constructing risk models. Results: After processing the raw data derived from GEO, we filtered out 1,401 DEGs, which were used in gene enrichment and building the PPI networks. Several processes were enriched. Three subtypes associated with fatty acid synthesis and tumor immunity in OC were identified based on six critical genes ( Conclusions: This study enhances our understanding of the complex molecular mechanisms underlying OC by highlighting the interplay between tumor immunity and fatty acid synthesis. The identification of three distinct subtypes based on key genes provides a new framework for categorizing OC patients, which could lead to more personalized therapeutic approaches. The prognostic model related to fatty acid synthesis not only offers potential biomarkers for predicting patient outcomes but also suggests new avenues for targeted therapies. These findings could pave the way for more effective immune-based treatments and improve the prognosis for OC patients. Future research should focus on validating these biomarkers and exploring their functional roles in OC pathogenesis and treatment response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.